INTERNATIONAL PATENT: EIKON THERAPEUTICS, INC. FILES APPLICATION FOR "RESIQUIMOD IN COMBINATION WITH A PD-1 OR PD-L1 ANTAGONIST FOR TREATING CANCER"

GENEVA, Dec. 10 -- EIKON THERAPEUTICS, INC. (230 Harriet Tubman WayMillbrae, CA 94030) filed a patent application (PCT/US2025/031575) for "RESIQUIMOD IN COMBINATION WITH A PD-1 OR PD-L1 ANTAGONIST FOR TREATING CANCER" on May 30, 2025. With publication no. WO/2025/250888, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RAFTOPOULOS, Haralambos (c/o Eikon Therapeutics, INC.230 Harriet Tubman WayMillbrae, CA 94030)

Abstract: The present disclosure relates to compositions and methods for treating cancer comprising the adminis...